Remegen (9995.HK)

Remegen share price today, ATLAS forecast and fair value

Healthcare · Biotechnology · Hong Kong Exchanges (HKEX) · Hong Kong SAR China

HK$62.35▼ -3.33%

Prices as of Oct 27, 2026 · HKD

ATLAS fair value

ATLAS has no fair value for this stock today.

Chance of rising in 1 month

48%

that it ends higher than today in 21 sessions

0%coin flip 50%100%

This is just the summary. See everything on Remegen in ATLAS

ATLAS's own quantitative analysis, all in one place.

Simulation and expected rangeThousands of simulated scenarios: how far the price could rise or fall.
Officers and shareholdersWho runs the company and which funds hold its shares.
Customer and supplier mapWho it does business with, from its own filings.
ATLAS builds your portfolioAnswer a short test and get portfolios that fit you.
AlertsWe let you know when something changes in your stocks.

See everything included

Valuation and financialsFair value step by step, quarterly accounts and upcoming events.
NewsThe latest on the company, in one place.
Crisis simulatorHow your portfolio would do in a crash like 2008.
Practice risk-free$10,000 in virtual money to invest at real prices.
Global screenerSearch US stocks and stocks from 47 countries with filters.

On Remegen

Simulation and expected rangeThousands of simulated scenarios: how far the price could rise or fall.
Officers and shareholdersWho runs the company and which funds hold its shares.
Customer and supplier mapWho it does business with, from its own filings.
Valuation and financialsFair value step by step, quarterly accounts and upcoming events.
NewsThe latest on the company, in one place.

And for you

ATLAS builds your portfolioAnswer a short test and get portfolios that fit you.
AlertsWe let you know when something changes in your stocks.
Crisis simulatorHow your portfolio would do in a crash like 2008.
Practice risk-free$10,000 in virtual money to invest at real prices.
Global screenerSearch US stocks and stocks from 47 countries with filters.

Get started →

Plans from €3.99 a month.

ATLAS's model gives Remegen a 48% chance of finishing higher a month from now (21 trading sessions) than today: close to a coin flip.

In half of the simulated outcomes the price ends between HK$55.71 and HK$68.51; in 9 out of 10, between HK$46.37 and HK$82.31. Estimated annual volatility is 51%.

Price, last 12 months (weekly close)

Key numbers

P/E ratio: 5.8
52-week high: HK$123.10
52-week low: HK$60.00
Revenue (12 months): CN¥8.0B
Gross margin: 93.9%
Operating margin: 84.5%
Net margin: 72.7%
Beta: 0.46

What this means

ATLAS does not publish a fair value for 9995.HK right now, but it does show its odds of rising: close to a coin flip.

Over the last 52 weeks 9995.HK has traded between HK$60.00 and HK$123.10. Today it is 49.4% below that high and 4% above its low.

On the business: net margin is 72.7%; it trades at 5.8 times earnings.

Its beta is 0.46: it tends to move less than the market.

About the company

RemeGen Co., Ltd., a biopharmaceutical company, discovers, develops, produces, and commercializes biological drugs for the treatment of autoimmune, oncology, and ophthalmic diseases in Mainland China and the United States.

Want to see everything about Remegen?

Get started →

Plans from €3.99 a month.

Comparable companies

Other companies in the same line of business:

Frequently asked questions

What does Remegen do?

What is the chance 9995.HK goes up next month?

48%: close to a coin flip. In half of the simulated outcomes, 9995.HK ends the month between HK$55.71 and HK$68.51.

How big is Remegen and what is its P/E ratio?

Its price-to-earnings (P/E) ratio is 5.8: you pay HK$5.76 for each HK$1.00 of yearly earnings.

How volatile is 9995.HK?

ATLAS estimates annual volatility at 51%. In a typical month, half of the outcomes end between HK$55.71 and HK$68.51.

Not investment advice. ATLAS estimates are produced by statistical models from public data; they can be wrong and past performance does not predict future results. Consider your own situation before investing. Disclaimer